MeSH tree: C04.557.450.590
Uterine fibroids and endometriosis are two of the most common gynecologic diseases, affecting 15% to 80% of women of childbearing age. Existing treatments—hormonal drugs and selective estrogen receptor modulators—have side ...
Endometriosis and uterine fibroids are two of the most common gynecological conditions. While they have important differences, they also have things in common. Both can lead to serious complications, affect fertility and ...
Jun 11, 2026
0
5
A cancer researcher at the University of Houston is reporting what makes malignant soft tissue cancer grow in children, identifying key mechanisms and molecular targets to prevent tumor progression in patients in future therapies ...
Jun 9, 2026
0
6
Uterine fibroids may be less common in Latina women than earlier estimates suggested, according to new research. The study, led by researchers at Michigan Medicine, is one of the largest in the U.S. to confirm fibroid cases ...
Apr 27, 2026
0
5
Long-term adverse events were rare and manageable among patients with alveolar soft part sarcoma (ASPS), which primarily affects adolescents and young adults, who received immunotherapy beyond the standard two years, according ...
Apr 20, 2026
0
5
It is a process as old as humanity itself, yet there is still much we do not know about women's menstrual cycle and the impact it has on the entire body. Now, a team of researchers from the Department of Clinical Medicine ...
Apr 16, 2026
0
13
Paired Box 3 (PAX3) is a protein that plays a critical role in the formation of tissues and organs during embryonic development and can positively (and less frequently, negatively) regulate gene expression. While progress ...
Mar 18, 2026
0
3
An oral combination treatment may prevent the progression of advanced leiomyosarcoma, one of the most common subtypes of soft tissue sarcoma, according to a recent study published in The Lancet Oncology. "These findings support ...
Feb 10, 2026
0
42
The U.S. Food and Drug Administration (FDA) has again missed a deadline to propose a ban on chemicals in hair-straightening products that may pose a serious cancer risk.
Jan 8, 2026
0
9
A UK study has revealed that acute heavy menstrual bleeding (HMB) is placing a significant hidden burden on the NHS, with around £13 million spent annually on hospital admissions and post-discharge care.
Dec 10, 2025
0
11
